Prostate Cancer Treatment

Prostate Cancer
The uncontrolled growth of cells around the outer region of the prostate, which gives rise to the development of a malignant tumor, is called prostate cancer. Prostate cancer is common among American males. Over 250,000 cases are diagnosed in the United States every year. Early signs of prostate cancer are difficult to detect. Symptoms only set in once the tumor spreads. Change in urination habits with increased frequency or dribbling are the fi Read More...
The Big News About Herbal Treatment For Prostate Cancer
A very deceptive cancer that affects the prostate, does not start early, but does grow fast once it does start. This cancer like many can be life threatening as well as very damaging. Many people afflicted with this type of cancer do not even realize anything is wrong until it becomes a nightmare. Prostate cancer affects men and their sexual performance as well as the other sexual functions. More so, older men should be concerned about developin Read More...
Frequently Asked Questions About Metastatic Prostate Cancer
Cancer is a scary diagnosis. Whether you are a man or a woman, cancer is a real threat. For men, one of the most common forms of cancer is metastatic prostate cancer. It is very important that men have regular prostate screening and if tumors or cancer is present, to seek immediate medical attention. Here are some commonly asked questions regarding metastatic prostate cancer. What is metastatic prostate cancer? Metastatic prostate cancer is sim Read More...

How Radiation Treatment For Prostate Cancer Works
An Effective Prostate Cancer Treatment Option
What Prostate Cancer Treatment Is Right For You

RELATED NEWS

First-degree family history of prostate cancer does not affect some treatment outcomes (News-Medical-Net)
In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy (also called seed implants), and patients with this type of family history have clinical and pathologic characteristics similar to men with no family history at all, according to a January 1 study in the International ... Read More...
Family History Of Prostate Cancer Does Not Affect Some Treatment Outcomes (Medical News Today)
In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy (also called seed implants), and patients with this type of family history have clinical and pathologic characteristics similar Read More...
Family History Of Prostate Cancer Does Not Affect Some Treatment Outcomes (Science Daily)
In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy, also called seed implants, and patients with this type of family history have clinical and pathologic characteristics similar to men with no family history at all, according to a study in the International Journal of ... Read More...
Family history of prostate cancer does not affect some treatment outcomes (EurekAlert!)
( American Society for Therapeutic Radiology and Oncology ) In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy, also called seed implants, and patients with this type of family history have clinical and pathologic characteristics similar to men with no family history at all, ... Read More...
CureVac wins approval to initiate Phase I/IIa prostate cancer vaccine study (Pharmaceutical Business Review)
CureVac, a biopharmaceutical company, has received approval for its investigational new drug application with the FDA to begin a Phase I/IIa clinical study with CV9103, an RNActive-derived mRNA vaccine, that will be tested in patients with hormone-refractory metastatic prostate cancer. Read More...
GTx submits NDA for toremifene to treat bone fractures in men with prostate cancer (PharmaBiz)
GTx, Inc announced the submission of a New Drug Application with the US Food and Drug Administration (FDA) for toremifene 80 mg, an oral selective estrogen receptor modulator (SERM), for the prevention of bone fractures in men with prostate cancer on androgen deprivation therapy (ADT). Read More...
Family history of prostate cancer does not affect outcomes of seed implant therapy (New Kerala)
Washington, January 3 : A new study has revealed that a first-degree family history of prostate cancer does not have any impact on the treatment outcomes of patients treated with brachytherapy, also known as seed implants. Read More...
Prostate Cancer Options Abound (New London Day)
In the past year, southeastern Connecticut's two hospitals both purchased expensive new equipment employing the latest technologies to treat prostate cancer, a disease diagnosed in Read More...
Why Prostate Cancer Patients Fail Hormone Deprivation (Medical News Today)
The hormone deprivation therapy that prostate cancer patients often take gives them only a temporary fix, with tumors usually regaining their hold within a couple of years. Now, researchers at Johns Hopkins have discovered critical differences in the hormone receptors on prostate cancer cells in patients who no longer respond to this therapy. The findings, reported in the Jan. Read More...
Speedy recovery: Stamford Hospital uses CyberKnife to treat cancer (Norwalk Advocate)
STAMFORD - Doug Walker dressed for the first bout of radiation for prostate cancer like he was going to the beach - Hawaiian shorts, sneakers and a T-shirt. Read More...